GlobeNewsWire · PPCB · October 14, 2026

Propanc Biopharma Announces Publication of Pilot Study Demonstrating Potent Anti-Tumor Efficacy of PRP Pancreatic Proenzyme Formulation in Pancreatic & Ovarian Cancer

Get the app for more

Explore stock news, insights and company research.